Clinical efficacy of trans-jugular transcatheter closure of atrial septal defect solely under echocardiography guidance in infants
- VernacularTitle:单纯超声引导下经颈静脉途径封堵婴幼儿房间隔缺损临床疗效
- Author:
Hao SHI
1
;
Xiangbin PAN
1
;
Shouzheng WANG
1
;
Yongquan XIE
1
Author Information
1. Center of Structural Heart Disease, Fuwai Hospital, Chinese Academy of Medical Science, National Center for Cardiovascular Diseases, Beijing, 100037, P.R.China
- Publication Type:Journal Article
- Keywords:
Atrial septal defect;
echocardiography;
internal jugular vein;
interventional treatment
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(06):645-648
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the key points, indications and safety of trans-jugular transcatheter closure of atrial septal defect (ASD) in infants. Methods The clinical data of 53 infants with ASD from January 2017 to May 2019 in our hospital were retrospectively reviewed. There were 20 males and 33 females with the age of 1.2 (0.5-2.9) years, and body weight of 9.0 (6.8-10.6) kg. The ASD diameter was 9.8 (8.0-14.0) mm. Thirty-one patients were treated under the guidance of transesophageal ultrasound (TEE), and the other 22 patients under the guidance of transthoracic echocardiography (TTE). We used the steerable curved sheath through the internal jugular vein under the guidance of echocardiography, and the average occluder size was 13.5±4.5 mm. Results All of the 53 patients were successfully occluded, and none of them changed to radiation-guided or transthoracic surgery. Postoperative hospital stay was 3.35±0.70 d. There was no complication such as peripheral vascular injury, occluder malposition or displacement, serious arrhythmia or pericardial effusion. The patients were followed up for 14.3±5.1 months without arrhythmia, residual shunt, occluder malposition or displacement or thrombus. Conclusion Echocardiography-guided trans-jugular closure of ASD for infants with low weight and large ASD shunt or patients with inferior vena cava abnormalities not suitable for femoral vein treatment, not only overcomes the radiation risk of radiation guidance, but also maintains the advantages of minimal invasiveness and safety, providing a new treatment option for such patients.
